Search
Toward an optimized assessment of adolescent psychopathology risk: Multilevel environmental profiles and child irritability as predictors
Stress, Coping, and Context: Examining Substance Use Among LGBTQ Young Adults With Probable Substance Use Disorders
In this research, the authors explored how lesbian, gay, bisexual, transgender, and queer (LGBTQ) young adults with problematic substance use made sense of their substance use in relation to their LGBTQ identities.
The authors interviewed...
Association of Mandatory Warning Signs for Cannabis Use During Pregnancy With Cannabis Use Beliefs and Behaviors
Abstract
Importance As states have legalized recreational cannabis use, some have enacted policies mandating point-of-sale warning signs with information on harms of using cannabis during pregnancy. While research has found such warning...
El fentanilo, información de NIDA
El fentanilo es un fuerte opioide sintético similar a la morfina, pero entre 50 y 100 veces más potente. Es un fármaco recetado que a veces también se usa en forma ilegal. Al igual que la morfina, por lo general se receta a pacientes con...
Fentanyl DrugFacts
Fentanyl is a powerful synthetic opioid that is similar to morphine but is 50 to 100 times more potent. It is a prescription drug that is also made and used illegally. Like morphine, it is a medicine that is typically used to treat patients...
Exploring the impact of the COVID-19 pandemic on healthcare and substance use service access among women who inject drugs: a qualitative study
Abstract
Background
The COVID-19 pandemic disrupted healthcare and substance use services engagement, including primary and mental health services as well as residential and outpatient drug treatment. Women who inject drugs (WWID) face...
Common developmental trajectories and clinical identification of children with fetal alcohol spectrum disorders: A synthesis of the literature
At an estimated prevalence of up to five percent in the general population, fetal alcohol spectrum disorders (FASD) are the most common neurodevelopmental disorder, at least if not more prevalent than autism (2.3%). Despite this prevalence...
Engaging Dads in Programs to Support Families Affected by Substance Use Disorders
September 21, 2022, National Center on Substance Abuse and Child Welfare
This webinar features experts from CREOKS Health Services in Oklahoma and Hushabye Nursery in Arizona. Panelists and NCSACW staff highlight the importance of...
Understanding the risks of mixing drugs
February 17, 2022
Mixing drugs, also known as polysubstance use, occurs when two or more drugs are taken together or within a short time period, intentionally or unintentionally. Even if someone has mixed drugs before, or mixes drugs often...
Datos sobre el uso de múltiples sustancias
Fuente: https://www.cdc.gov/stopoverdose/polysubstance-use/pdf/Spanish-Polysubstance-Factsheet-508.pdf
¿Qué es el uso de múltiples sustancias?
El uso de más de una droga, lo que se conoce como uso de múltiples sustancias, es frecuente...
Polysubstance Use Facts
What is polysubstance use?
The use of more than one drug, also known as polysubstance use, is common. This includes when two or more are taken together or within a short time period, either intentionally or unintentionally.
Intentional...
FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder
For Immediate Release: May 23, 2023
Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD)...
La FDA aprueba una nueva opción de tratamiento con buprenorfina para el trastorno por consumo de opioides
Para publicación inmediata: 24 de mayo del 2023
Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) aprobó la inyección subcutánea (para uso por debajo de la piel) de Brixadi...
Covering Substance Use and Addiction Responsibly
Economic Evaluations of Pharmacologic Treatment for Opioid Use Disorder: A Systematic Literature Review
Abstract
Objective
The crisis of opioid use puts a strain on resources in the United States and worldwide. There are 3 US Food and Drug Administration–approved medications for treatment of opioid use disorder: methadone, buprenorphine...
Implementace a strategie pracovních postupů pro integraci digitálních terapeutik pro poruchy spojené s užíváním alkoholu do primární péče: kvalitativní studie
Abstraktní
Pozadí
Poruchy spojené s užíváním alkoholu (AUD) jsou rozšířené a často se neléčí. Pacienti jsou běžně vyšetřováni na AUD v primární péči, ale stávající léčebné programy nedokážou uspokojit poptávku. Digitální terapie zahrnují...
Ingestion of Illicit Substances by Young Children Before and During the COVID-19 Pandemic
Abstract
Importance Information about the trend in illicit substance ingestions among young children during the pandemic is limited.
Objectives To assess immediate and sustained changes in overall illicit substance ingestion rates among...
Alcohol and Other Substance Use Before and During the COVID-19 Pandemic Among High School Students — Youth Risk Behavior Survey, United States, 2021
Abstract
Adolescence is a critical phase of development and is frequently a period of initiating and engaging in risky behaviors, including alcohol and other substance use. The COVID-19 pandemic and associated stressors might have affected...
PTACC Annual Deflection Summit Call for International Presenters
Proposals are now being accepted for the 2023 Police, Treatment, and Community Collaborative’s (PTACC) National Deflection and Pre-arrest Diversion Summit.
All submissions must be uploaded by May 5, 2023 at 2:00 EDT in order to be...
Share the Knowledge: ISSUP members can post in the Knowledge Share – Sign in or become a member